Collateral damage of COVID-19 pandemic on oncology clinical trials

Sri Harsha Tella; Anuhya Kommalapati; Steve R. Alberts; Robert McWilliams; Amit Mahipal

doi:10.21037/CCO-20-200

Collateral damage of COVID-19 pandemic on oncology clinical trials

Sri Harsha Tella, Anuhya Kommalapati, Steve R. Alberts, Robert McWilliams, Amit Mahipal

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	56350
Journal	Chinese clinical oncology
Volume	9
Issue number	6
DOIs	https://doi.org/10.21037/CCO-20-200
State	Published - 2020

ASJC Scopus subject areas

Oncology

Access to Document

10.21037/CCO-20-200

Cite this

@article{7e9f2af526644f749f31b20527891f55,

title = "Collateral damage of COVID-19 pandemic on oncology clinical trials",

author = "Tella, {Sri Harsha} and Anuhya Kommalapati and Alberts, {Steve R.} and Robert McWilliams and Amit Mahipal",

year = "2020",

doi = "10.21037/CCO-20-200",

language = "English (US)",

volume = "9",

journal = "Chinese clinical oncology",

issn = "2304-3865",

publisher = "Society for Translational Medicine (STM)",

number = "6",

}

TY - JOUR

T1 - Collateral damage of COVID-19 pandemic on oncology clinical trials

AU - Tella, Sri Harsha

AU - Kommalapati, Anuhya

AU - Alberts, Steve R.

AU - McWilliams, Robert

AU - Mahipal, Amit

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85097831575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097831575&partnerID=8YFLogxK

U2 - 10.21037/CCO-20-200

DO - 10.21037/CCO-20-200

M3 - Letter

C2 - 33222443

AN - SCOPUS:85097831575

SN - 2304-3865

VL - 9

JO - Chinese clinical oncology

JF - Chinese clinical oncology

IS - 6

M1 - 56350

ER -

Collateral damage of COVID-19 pandemic on oncology clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this